• Focused on improving patient care

  • Quality matters

  • Understanding the fragility and value of life

  • Developing future solutions for unmet patient needs


Newsroom

22.01.2018
Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

Lachen, Switzerland, January 22nd, 2018: Octapharma is delighted to announce the publication of fina...

21.11.2017
Octapharma donates 30.5 million international units of its medicine Nuwiq® to treat people with haemophilia in developing countries

Lachen, Switzerland, November 21st, 2017: Octapharma is pleased to announce the completion of a char...

Octapharma’s success is the result of the combined contribution of all employees, what we call “the human factor”. To embark on a challenging and rewarding career in an innovative biopharmaceutical organization, explore our global opportunities 

Octapharma is on a quest to make a difference in the lives of patients worldwide. This film tells the story of a man who is empowered to confront nature and take control of his life and his destiny.